-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Xilio Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q3 2024.
- Xilio Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.57M, a 15.4% decline year-over-year.
- Xilio Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.85M, a 5.77% decline year-over-year.
- Xilio Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.38M, a 12.4% decline from 2022.
- Xilio Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.42M, a 69.9% increase from 2021.
- Xilio Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.96M, a 283% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)